A Novel ABCD1 G1202A Mutation in a Chinese Patient with Pure Adrenomyeloneuropathy and Literature Review

Yu Zhang,Guoyong Zhang,Wenhui Chen,Zheng Pu,Lu Song,Xinghua Tang,Zhenguo Liu
DOI: https://doi.org/10.1016/j.gendis.2020.01.009
IF: 7.376
2021-01-01
Genes & Diseases
Abstract:Adrenomyeloneuropathy (AMN) is a kind of varied disease caused by ABCD1 gene mutation and characterized by very-long-chain fatty acids (VLCFA) accumulation. It is diagnosed by clinical features, high VLCFAs levels and ABCD1 gene mutation. AMN is rarely reported in Chinese population. In this study, we report the genetic and clinical features of a Chinese pure AMN patient. Meanwhile, we conducted a literature review of AMN cases to summarize the characteristics of AMN. We report a rare Chinese pure AMN case with slowly progressive weakness of the lower extremities, caused by a novel c.1202G > A mutation in ABCD1 gene. The literature review indicates that spastic paraplegia is the mainly clinical manifestation in patients with AMN. VLCFAs and ABCD1 gene test should be performed in patients with spastic paraplegia of the lower limbs to diagnose AMN.
What problem does this paper attempt to address?